Skip to main content
TipRanks
Go Ultimate75% OFF

Abbott Laboratories (ABT) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

ABT Analyst Ratings

Strong Buy
18Ratings
16Buy2Hold0Sell
Based on 18 analysts giving stock ratings to Abbott Laboratories in the past 3 months

ABT Stock 12 Month Forecast

CHF102.43â–²(12.56% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Abbott Laboratories in the last 3 months. The average price target is CHF 102.43 with a high forecast of CHF 113.28 and a low forecast of CHF 96.50. The average price target represents a 12.56% change from the last price of CHF 91.00.
Highest Price TargetCHF113.28Average Price TargetCHF102.43Lowest Price TargetCHF96.50

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:ABT
Price TargetArticle
Bank of America SecuritiesCHF96.50→CHF104.89buy15.27%UpsideReiterated11/09/26
Piper SandlerCHF99.02buy8.81%UpsideReiterated11/02/26
Argus Research―hold―Downgraded10/26/26
Wells FargoCHF99.86→CHF100.70buy10.66%UpsideReiterated10/23/26
Evercore ISICHF104.05→CHF100.70buy10.66%UpsideReiterated10/23/26
CitiCHF104.89→CHF102.37buy12.50%UpsideAssigned10/22/26
BarclaysCHF100.70buy10.66%UpsideReiterated10/22/26
Robert W. BairdCHF101.54→CHF103.21buy13.42%UpsideReiterated10/22/26
TD CowenCHF113.28→CHF99.02buy8.81%UpsideAssigned10/22/26
Oppenheimer Analyst forecast on CH:ABTUnknown AnalystNot RankedOppenheimerCHF96.50buy6.04%UpsideReiterated10/22/26
Stifel NicolausCHF100.70buy10.66%UpsideReiterated10/22/26
J.P. MorganCHF100.70→CHF99.02buy8.81%UpsideReiterated10/22/26
BTIGCHF112.44→CHF104.89buy15.27%UpsideReiterated10/21/26
RBC CapitalCHF109.09→CHF104.89buy15.27%UpsideReiterated10/21/26
Leerink Partners Analyst forecast on CH:ABTUnknown AnalystNot RankedLeerink Partners―hold―Reiterated10/12/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Abbott Laboratories

3 Months
Success Rate17/23 ratings generated profit
74%
Average Return
+3.06%

Copying Matthew Taylor's trades and holding each position for 3 Months would result in 73.91% of your transactions generating a profit, with an average return of +3.06% per trade.

1 Year
Jayson Bedford
Jayson BedfordRaymond James
Success Rate34/43 ratings generated profit
79%
Average Return
+14.90%

Copying Jayson Bedford's trades and holding each position for 1 Year would result in 79.07% of your transactions generating a profit, with an average return of +14.90% per trade.

2 Years
Success Rate17/23 ratings generated profit
74%
Average Return
+28.23%

Copying Matthew Taylor's trades and holding each position for 2 Years would result in 73.91% of your transactions generating a profit, with an average return of +28.23% per trade.

ABT Analyst Recommendation Trends

020406080Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ABT
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy3342363827
Hold00022
Sell00000
Strong Sell00000
total3342364029

In the current month, ABT has received 27 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ABT average Analyst price target in the past 3 months is 102.43.

ABT Financial Forecast

CHF-1CHF-0.25CHF0.5CHF1.25CHF2Q1 2026Q3 2026Q4 2026
HighCHF1.37
ConsensusCHF1.37
LowCHF1.36

ABT Earnings Forecast

Next quarter’s earnings estimate for ABT is CHF 1.37 with a range of CHF 1.36 to CHF 1.37. The previous quarter’s EPS was CHF 1.19. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF9.3BCHF9.8BCHF10.2BCHF10.7BCHF11.1BQ1 2026Q3 2026Q4 2026
HighCHF11.1B
ConsensusCHF11B
LowCHF11B

ABT Sales Forecast

Next quarter’s sales forecast for ABT is CHF 11.03B with a range of CHF 10.98B to CHF 11.14B. The previous quarter’s sales results were CHF 10.87B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ABT Stock Forecast FAQ

What is CH:ABT’s average 12-month price target, according to analysts?
Based on analyst ratings, Abbott Laboratories’s 12-month average price target is CHF102.43.
What is CH:ABT’s upside potential, based on the analysts’ average price target?
Abbott Laboratories has 12.56% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Abbott Laboratories a Buy, Sell or Hold?
Abbott Laboratories has a consensus rating of Strong Buy, which is based on 16 buy ratings, 2 hold ratings and 0 sell ratings.
What is Abbott Laboratories’s share price target?
The average share price target for Abbott Laboratories is CHF102.43. This is based on 18 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF113.28, and the lowest forecast is CHF96.50. The average share price target represents a 12.56% increase from the current price of CHF91.
What do analysts say about Abbott Laboratories?
Abbott Laboratories’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Street analysts.
How can I buy shares of Abbott Laboratories?
To buy shares of CH:ABT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.